• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Neuropathology Market Trends

    ID: MRFR/Pharma/3543-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Neuropathology Market Research Report By Diagnosis (Biopsy, Body Fluids, Peripheral Blood Smears, others), Application (Cerebral Hypoxia & Stroke, Perinatal Disorders, CNS Infections, Demyelinative Diseases, others), End User– Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Neuropathology Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Neuropathology Market

    The neuropathology market is changing because of a number of things. These reasons are better diagnostic tools, an older population, and more knowledge about brain diseases. All of these changes have an impact on neuropathology study, evaluation, and treatment. Neuropathology is getting better at using diagnostic technology. New imaging methods like MRI, PET, and genetic studies make brain illness diagnosis simpler. Treatments may be more targeted. It is becoming more common to tailor medicine to each person's genes, habits, and illness. In neuropathology, precision medicine is becoming more popular. This approach makes treatment more effective while lowering side effects. It does this by making the therapy environment more personalized and focused. Genomic and biomarker study is helping us figure out how brain diseases work at their core. Genetic markers and proteins that are tied to neuropathological diseases are being used to make diagnosis tools and treatment targets. It is getting better at treatment in neuropathology. Scientists are looking into how to change the immune system to fight brain diseases. This opens up new ways to change the situation and make things better for patients. More healthcare groups, study schools, and drug companies are working together on projects. These relationships help a team-based approach to neuropathology by sharing resources and experts and speeding up the creation of new medicines and treatments for many neurological conditions. Neuropathology is changing because of telemedicine and online patient tracking. Telehealth systems make it easier to get neural information, keep an eye on patients from afar, and improve follow-up care in places where access to expert healthcare is limited. Patient support and information efforts are giving people with neuropathological illnesses and their caretakers more power. To make patients smarter and more involved, these projects focus on education, support networks, and getting rid of the shame surrounding brain diseases. As more people become aware of brain diseases as a public health problem, the world market for neuropathology grows. This change is being caused by globalization, better healthcare facilities, and a greater understanding of how brain diseases affect society and the economy.

    Market Summary

    As per Market Research Future Analysis, the Neuropathology Market was valued at USD 2.79 Billion in 2023 and is projected to grow to USD 7.74 Billion by 2032, with a CAGR of 8.14% from 2024 to 2032. The market is driven by the rising incidence of musculoskeletal conditions and advancements in medical diagnostic devices. Neuropathologists play a crucial role in diagnosing diseases through biopsy examinations, particularly for cerebrovascular disorders. The introduction of less invasive tests like epidermal nerve fiber density testing (ENFD) is enhancing diagnostic capabilities. The market is segmented by diagnostic tests, applications, and end-users, with significant growth observed in hospitals and research centers. North America leads the market due to high healthcare expenditure and advanced infrastructure, followed by Europe and the rapidly growing Asia Pacific region.

    Key Market Trends & Highlights

    The Neuropathology Market is witnessing significant growth driven by technological advancements and increasing disease prevalence.

    • Market Size in 2023: USD 2.79 Billion.
    • Projected Market Size by 2032: USD 7.74 Billion.
    • CAGR from 2024 to 2032: 8.14%.
    • North America holds the largest market share due to advanced healthcare infrastructure.

    Market Size & Forecast

    2023 Market Size USD 2.79 Billion
    2024 Projected Market Size USD 3.26 Billion
    2032 Projected Market Size USD 7.74 Billion
    CAGR (2024-2032) 8.14%.

    Major Players

    Key players include ARUP Laboratories, Therapath LLC, Abbott Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sakura Finetek USA Inc., Danaher Corporation, Quest Diagnostics Incorporated, Agilent Technologies Inc., and NeoGenomics Laboratories.

    Market Trends

    The Global Neuropathology Market is poised for substantial growth, driven by advancements in diagnostic technologies and an increasing prevalence of neurological disorders, which collectively underscore the critical need for enhanced neuropathological services.

    National Institutes of Health (NIH)

    Neuropathology Market Market Drivers

    Aging Population

    The aging population is a critical factor influencing the Global Neuropathology Market Industry. As life expectancy increases globally, the proportion of elderly individuals is rising, leading to a higher incidence of age-related neurological disorders. This demographic shift is prompting healthcare systems to adapt and expand their services to meet the needs of this population. For example, countries with rapidly aging populations are witnessing a surge in demand for neuropathological assessments and interventions. Consequently, the Global Neuropathology Market Industry is expected to grow substantially, with estimates suggesting it will reach 3.26 USD Billion in 2024, reflecting the urgent need for specialized care.

    Market Growth Projections

    The Global Neuropathology Market Industry is anticipated to experience robust growth over the next decade. Projections indicate that the market will expand from 3.26 USD Billion in 2024 to an impressive 9.79 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 10.51% from 2025 to 2035. Factors contributing to this expansion include advancements in diagnostic technologies, increasing prevalence of neurological disorders, and heightened research funding. The market's evolution is likely to be shaped by ongoing innovations and a growing emphasis on personalized medicine, which may further enhance the efficacy of neuropathological interventions.

    Increased Research Funding

    The surge in research funding from both public and private sectors is significantly impacting the Global Neuropathology Market Industry. Governments and organizations are increasingly investing in research initiatives aimed at understanding the complexities of neurological diseases. For instance, the National Institutes of Health (NIH) has allocated substantial resources to research on neurodegenerative disorders. This influx of funding not only supports the development of new diagnostic and therapeutic approaches but also fosters collaboration among researchers and institutions. As a result, the Global Neuropathology Market Industry is likely to benefit from enhanced innovation and discovery, contributing to its projected growth to 9.79 USD Billion by 2035.

    Growing Awareness and Education

    There is a growing awareness and education regarding neurological disorders among healthcare professionals and the general public, which is driving the Global Neuropathology Market Industry. Initiatives aimed at educating clinicians about the latest advancements in neuropathology are becoming more prevalent. Additionally, public health campaigns are raising awareness about the importance of early diagnosis and treatment of neurological conditions. This increased knowledge is likely to lead to higher demand for neuropathological services and products. As a result, the Global Neuropathology Market Industry is poised for growth, with projections indicating a significant expansion in the coming years.

    Rising Prevalence of Neurological Disorders

    The increasing incidence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, is a primary driver of the Global Neuropathology Market Industry. As the global population ages, the prevalence of these conditions is expected to rise significantly. For instance, it is estimated that by 2035, the number of individuals suffering from dementia will reach 115 million worldwide. This growing patient population necessitates advanced diagnostic and therapeutic solutions, thereby propelling the market forward. The Global Neuropathology Market Industry is projected to reach 3.26 USD Billion in 2024, reflecting the urgent need for innovative neuropathological assessments.

    Technological Advancements in Diagnostic Tools

    Technological innovations in diagnostic tools, such as advanced imaging techniques and molecular pathology, are transforming the landscape of the Global Neuropathology Market Industry. These advancements enhance the accuracy and speed of diagnoses, allowing for earlier intervention and improved patient outcomes. For example, the integration of artificial intelligence in imaging analysis is showing promise in identifying subtle changes in brain pathology. As these technologies become more widely adopted, they are likely to drive market growth. The Global Neuropathology Market Industry is expected to experience a compound annual growth rate of 10.51% from 2025 to 2035, indicating a robust demand for cutting-edge diagnostic solutions.

    Market Segment Insights

    Regional Insights

    Key Companies in the Neuropathology Market market include

    Industry Developments

    Future Outlook

    Neuropathology Market Future Outlook

    The Neuropathology Market is poised for growth at a 10.51% CAGR from 2024 to 2035, driven by advancements in diagnostic technologies and increasing prevalence of neurological disorders.

    New opportunities lie in:

    • Invest in AI-driven diagnostic tools to enhance accuracy and efficiency.
    • Develop targeted therapies for neurodegenerative diseases to capture emerging patient needs.
    • Expand global partnerships for research collaborations in neuropathology innovations.

    By 2035, the Neuropathology Market is expected to exhibit robust growth, reflecting advancements and increased demand.

    Market Segmentation

    Report Scope

    {}

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    At what CAGR is the neuropathology market projected to grow during the forecast period?

    Neuropathology market is projected to grow at a 8.14% CAGR between 2024- 2032.

    Which region is expected to dominate the neuropathology market?

    North America is expected to dominate the neuropathology market.

    Name the major end users of the neuropathology market.

    Research centers, clinics, hospitals, and others are the major end users of the neuropathology market.

    What are the key factors driving the neuropathology market?

    Technological advances in medical diagnostic devices and rising prevalence of musculoskeletal conditions are the key factors driving the neuropathology market.

    Who are the leading players profiled in the neuropathology market?

    Leading players profiled in the neuropathology market include NeoGenomics Laboratories, Agilent Technologies Inc., Quest Diagnostics Incorporated, Danaher Corporation, Sakura Finetek USA Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Therapath LLC, and ARUP Laboratories.

    1. TABLE OF CONTENT    
    2. Chapter 1.    Report Prologue    
    3. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective    
        2.     Assumptions    
        3.     Limitations    
    4. Chapter 3.    Research Methodology
      1.     Introduction
      2.     Primary Research    
      3.     Secondary research    
      4.     Market Size Estimation
    5. Chapter 4.    Market Dynamics
      1.     Drivers    
      2.     Restrains
      3.     Opportunities    
      4.     Challenges
      5.     Macroeconomic Indicators
      6.     Technology Trends & Assessment            
    6. Chapter 5.    Market Factor Analysis
      1.     Porter’s Five Forces Analysis
        1.     Bargaining Power of Suppliers    
        2.     Bargaining Power of Buyers
        3.     Threat of New Entrants    
        4.     Threat of Substitutes    
        5.     Intensity of Rivalry    
      2.     Value Chain Analysis
      3.     Investment Feasibility Analysis    
      4.     Pricing Analysis
    7. Chapter 6.    Global Neuropathology Market, by Diagnosis Test
      1.     Introduction
      2.     Biopsy 
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Body fluids 
    8.  6.3.1    Market Estimates & Forecast, 2020 – 2027
      1.     Peripheral blood smears 
        1.     Market Estimates & Forecast, 2020 – 2027
      2.     Biopsy 
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Tissue resections
    9.  6.6.1    Market Estimates & Forecast, 2020 – 2027
      1.     Others
        1.     Market Estimates & Forecast, 2020 – 2027
    10. Chapter 7.    Global Neuropathology Market, by Application 
      1.     Introduction
      2.     Cerebral hypoxia and stroke
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Perinatal disorders
        1.     Market Estimates & Forecast, 2020 – 2027
      4.     CNS infections
        1.     Market Estimates & Forecast, 2020 – 2027
      5.     Demyelinative diseases
        1.     Market Estimates & Forecast, 2020 – 2027
      6.     Brain tumors
        1.     Market Estimates & Forecast, 2020 – 2027
      7.     Neurodegenerative diseases
        1.     Market Estimates & Forecast, 2020 – 2027
      8.     Inherited metabolic disorders
        1.     Market Estimates & Forecast, 2020 – 2027
      9.     Peripheral neuropathy
        1.     Market Estimates & Forecast, 2020 – 2027
      10.     Myopathology
        1.     Market Estimates & Forecast, 2020 – 2027
      11.     Others
    11. Chapter 8.    Global Neuropathology Market, by End User
      1.     Introduction
      2.     Hospitals
        1.     Market Estimates & Forecast, 2020 – 2027
      3.     Clinics
        1.     Market Estimates & Forecast, 2020 – 2027
      4.     Research centers
        1.     Market Estimates & Forecast, 2020 – 2027
      5.     Others
        1.     Market Estimates & Forecast, 2020 – 2027
    12. Chapter .9    Global Neuropathology Market, by Region
      1.     Introduction
      2.     Americas
        1.     North America
        2.     South America
      3.     Europe
        1.     Western Europe
        2.     Eastern Europe
      4.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.     Rest of Asia Pacific
      5.     The Middle East & Africa
        1.     United Arab Emirates
        2.      Saudi Arabia
        3.     Rest of the Middle East & Africa 
    13. Chapter 10    Company Landscape    
      1.     Introduction    
      2.     Market Share Analysis    
      3.     Key Development & Strategies    
        1.     Key Developments    
    14. Chapter 11    Company Profiles    
      1.     Abbott Laboratories 
        1.     Company Overview    
        2.     Product Overview    
        3.     Financials    
        4.     SWOT Analysis    
      2.     Therapath LLC    
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     ARUP Laboratories
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      4.     Laboratory Corporation of America Holdings
        1.     Company Overview    
        2.     Product/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      5.     F. Hoffmann-La Roche Ltd
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments    
      6.     Danaher Corporation
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
      7.     Quest Diagnostics Incorporated
        1.     Overview    
        2.     Product Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
      8.     NeoGenomics Laboratories
        1.     Company Overview    
        2.     Product/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      9.     Agilent Technologies Inc.
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments    
      10.     Others
    15. Chapter 12    MRFR Conclusion    
      1.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
      2.     Key Companies to Watch    
      3.     Prediction of Pharmaceutical industry
    16. Chapter 13    Appendix
    17. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1        Neuropathology Industry Synopsis, 2020 – 2027
      3. Table 2        Neuropathology Market Estimates and Forecast, 2020 – 2027, (USD Million)
      4. Table 3        Neuropathology Market by Region, 2020 – 2027, (USD Million)
      5. Table 4        Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      6. Table 5        Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      7. Table 6        Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      8. Table 7        North America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      9. Table 8     North America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      10. Table 9     North America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      11. Table 10    US Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      12. Table 11    US Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      13. Table 12    US Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      14. Table 13    Canada Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      15. Table 14    Canada Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      16. Table 15    Canada Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      17. Table 16    South America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      18. Table 17    South America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      19. Table 18    South America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      20. Table 19    Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      21. Table 20    Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      22. Table 21    Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      23. Table 22    Western Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      24. Table 23    Western Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      25. Table 24    Western Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      26. Table 25    Eastern Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      27. Table 26    Eastern Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      28. Table 27    Eastern Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      29. Table 28    Asia Pacific Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      30. Table 29    Asia Pacific Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      31. Table 30    Asia Pacific Neuropathology Market by End Users, 2020 – 2027, (USD Million)
      32. Table 31    Middle East & Africa Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
      33. Table 32    Middle East & Africa Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
      34. Table 33    Middle East & Africa Neuropathology Market by End Users, 2020 – 2027, (USD Million)   LIST OF FIGURES
      35. Figure 1    Research Process
      36. Figure 2    Segmentation for Neuropathology Market
      37. Figure 3    Segmentation Market Dynamics for Neuropathology Market
      38. Figure 4    Global Neuropathology Market Share, by Diagnosis 2020
      39. Figure 5    Global Neuropathology Market Share, by Treatment 2020
      40. Figure 6    Global Neuropathology Market Share, by End Users, 2020
      41. Figure 7    Global Neuropathology Market Share, by Region, 2020
      42. Figure 8    North America Neuropathology Market Share, by Country, 2020
      43. Figure 9    Europe Neuropathology Market Share, by Country, 2020
      44. Figure 10    Asia Pacific Neuropathology Market Share, by Country, 2020
      45. Figure 11    Middle East & Africa Neuropathology Market Share, by Country, 2020
      46. Figure 12    Global Neuropathology Market: Company Share Analysis, 2020 (%)
      47. Figure 13    Abbott Laboratories.: Key Financials
      48. Figure 14    Abbott Laboratories, Inc.: Segmental Revenue
      49. Figure 15    Abbott Laboratories.: Geographical Revenue
      50. Figure 16    Therapath LLC: Key Financials
      51. Figure 17    Therapath LLC: Segmental Revenue
      52. Figure 18    Therapath LLC: Geographical Revenue
      53. Figure 19    ARUP Laboratories: Key Financials
      54. Figure 20    ARUP Laboratories: Segmental Revenue
      55. Figure 21    ARUP Laboratories: Geographical Revenue
      56. Figure 22    Laboratory Corporation of America Holdings: Key Financials
      57. Figure 23    Laboratory Corporation of America Holdings: Segmental Revenue
      58. Figure 24    Laboratory Corporation of America Holdings: Geographical Revenue
      59. Figure 25    F. Hoffmann-La Roche Ltd: Key Financials
      60. Figure 26    F. Hoffmann-La Roche Ltd: Segmental Revenue
      61. Figure 27    F. Hoffmann-La Roche Ltd: Geographical Revenue
      62. Figure 28    Danaher Corporation: Key Financials
      63. Figure 29    Danaher Corporation: Segmental Revenue
      64. Figure 30    Danaher Corporation: Geographical Revenue
      65. Figure 31    Quest Diagnostics Incorporated: Key Financials
      66. Figure 32    Quest Diagnostics Incorporated: Segmental Revenue
      67. Figure 33    Quest Diagnostics Incorporated: Geographical Revenue
      68. Figure 34    NeoGenomics Laboratories: Key Financials
      69. Figure 35    NeoGenomics Laboratories: Segmental Revenue
      70. Figure 36    NeoGenomics Laboratories: Geographical Revenue
      71. Figure 37    Agilent Technologies Inc: Key Financials
      72. Figure 38    Agilent Technologies Inc: Segmental Revenue
      73. Figure 39    Agilent Technologies Inc: Geographical Revenue

    Neuropathology Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027